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Abstract 
BACKGROUND: Fast Orally Dissolving Film preparation can be used for patients with problems in ingesting solid 
dosage forms, such as mentally ill, elderly, geriatric and patients who are reducing fluid intake or nausea. 
AIM: This study aimed to formulate and evaluate the rapid dissolution of amlodipine besylate. 
METHODS: Amlodipine besylate film was prepared by solvent casting method by using hydroxypropyl 
methylcellulose (HPMC) as film formers, crospovidone as superdisintegrant with Varian concentration F1 (2%), F2 
(4%), F3 (6%) and F4 (8%), PEG 400 as plasticizer, sucralose and sorbitol as sweetener, citric acid as saliva 
stimulation, and grape essence as flavoring and coloring agent. Characteristics of films include organoleptic, 
weight uniformity, film thickness, surface pH, swelling, uniformity of content, time of disintegration, and dissolution. 
RESULTS: All formulated films produced a good film, smooth, transparent and uniform physical properties. F2 
with polymer HPMC and the 4% concentration of crospovidone was the best formula with 31.50 seconds of 
disintegration time, the index expanding at the 15 second by 242.29% and the cumulative percent of the drug at 
80 seconds by 98.08%. 
CONCLUSION: Amlodipine besylate can be formulated into fast orally dissolving film preparations using HPMC 
and crospovidone polymers so that they may be considered for use in the treatment of hypertension for patients 
with drug-induced problems in tablet or capsule form. 
 
 
 
 
 
Introduction 
 
Recently, fast dissolving films are gaining 
interest as an alternative to fast dissolving tablets. The 
films are designed to dissolve upon contact with a wet 
surface, such as the tongue, within a few seconds, 
meaning the consumer can take the product without 
the need for additional liquid. This convenience 
provides a marketing advantage and increased patient 
compliance. As the drug is directly absorbed into 
systemic circulation, degradation in the 
gastrointestinal tract and first pass effect can be 
avoided [1]. 
Fast dissolving drug delivery systems were 
first invented in the late 1970s as to overcome 
swallowing difficulties associated with tablets and 
capsules for pediatric and geriatric patients. Buccal 
drug delivery has lately become an important route of 
drug administration. Various bioadhesive mucosal 
dosage forms have been developed, which includes 
adhesive tablets, gels, ointments, patches, and more 
recently the use of polymeric films for buccal delivery, 
also known as orally dissolving films [1]. Bioavailability 
of the drug will be enhanced due to high blood flow 
since the permeability of oral mucosa is 4-1000 times 
greater than that of skin [2]. 
Thin films have shown the capabilities to 
improve the onset of drug action, reduce the dose 
frequency and enhance the drug efficacy [3]. These 
points make this formulation most popular and 
acceptable among pediatric and geriatric patients and 
patients with fear of choking [1]. 
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Advantages over conventional dosage 
 forms 
A thin film dissolves faster than other 
conventional dosage forms. Thin films are less friable 
and easy to carry dosage form compared to 
commercialized orally fast disintegrating tablets, which 
need special packing. Likewise, a single dose of the 
strip can be carried individually without requiring the 
secondary container. It is very important to pay 
attention the poor stability of liquid dosage forms, 
especially the aqueous formulations. Unlike the thin 
films, there is a need for great care during accurate 
measurement of the amount and shaking the bottle 
every time before administration may contribute to 
less acceptance by the patients [4]. 
Amlodipine is a calcium channel blocker used 
in the management of hypertension and angina 
pectoris. It is long-acting with effects similar to 
nifedipine. Administered orally, the drug is well 
absorbed and peak blood concentration is reached 
after 6-12 h. Plasma elimination is biphasic and 
terminal elimination half-life is about 30-50 h. The 
absolute bioavailability of between 60 and 65% has 
been estimated [4]. 
Amlodipine is a calcium antagonist (calcium 
ion antagonist or slow-channel blocker) that inhibits 
the transmembrane influx of calcium ions into vascular 
smooth muscle and cardiac muscle. The contractile 
processes of cardiac muscle and vascular smooth 
muscle are dependent upon the movement of 
extracellular calcium ions into these cells through 
specific ion channels. Amlodipine inhibits calcium ion 
influx across cell membranes selectively, with a 
greater effect on vascular smooth muscle cells than 
on cardiac muscle cells [5]. 
 
 
Material and Methods 
 
The materials used in this research are 
amlodipine besylate (Unichem Laboratory, Ltd), PEG 
400 (Brataco), sorbitol, sucralose, citric acid, HPMC 
(Wuhan Senwayer Century Chemical Co., Ltd.), 
crospovidone (Huangshan Bonsun Pharmaceuticals 
Co., Ltd.), sodium hydroxide (Merck), ascorbic acid 
(Merck) and distilled Water (Brataco). 
 The ODF preparation was prepared by using 
HPMC and crospovidone polymers by solvent casting 
method. All materials were weighed. A number of film-
forming polymer solutions were developed in distilled 
water for 15 minutes. An amount of sorbitol and 
sucralose were dissolved in 5 ml of distilled water and 
then added citric acid. The solution was stirred until 
completely dissolved then added PEG 400, 
crospovidone and tween 80 and grape essence added 
with constant stirring for 45 min. The solution mixture 
was allowed to stand at room temperature to remove 
air bubbles. The film solution was poured into a 9x10 
cm mold and then dried for 24 hours. After drying, the 
film was removed from the mold then cut to 2x3 cm so 
that each film contains 5 mg of amlodipine besylate. 
The formula can be seen in Table 1. 
Table 1: The formulation of fast orally dissolving films 
Material (mg) Formula 
F1 F2 F3 F4 
Amlodipine besylayte 75 75 75 75 
HPMC 250 250 250 250 
Crospovidone (% w/w) 2 4 6 8 
PEG 400 40 40 40 40 
Citric acid 35 35 35 35 
Tween 80 q.s q.s q.s q.s 
Sorbitol 30 30 30 30 
Sucralose 20 20 20 20 
Grape essence q.s. q.s. q.s. q.s. 
Distilled water 15 15 15 15 
Note: q.s. = quantum satis = sufficiently. 
 
The organoleptic characteristics of the 
amlodipine besylate ODF preparations observed 
included homogeneity, color, odor, and texture 
visually seen by 10 panelists. 
For the evaluation of the weight of the film, six 
sheets of each formula were taken and weighed one 
by one and then determined the standard deviation. 
The film thickness was measured in the middle and 
the four corners. The average film thickness value 
was calculated and the standard deviation should be 
less than 5%. For the evaluation of the pH of the 
preparation, a film was dissolved in 10 ml of distilled 
water in the container and the pH of the preparation 
was measured using a pH meter. Measurements were 
made of three films of each formula.  
Uniformity of amlodipine besylate content was 
determined by dissolving one sheet of film with 
phosphate buffer pH 6.8 in a 100 ml measuring flask, 
1 ml of solution was then diluted with phosphate buffer 
pH 6.8 to 10 ml. Amlodipine besylate levels were 
determined by spectrophotometer at a wavelength of 
364 nm. Measurements were made of three films of 
each formula. 
Disintegration time of the film was performed 
by using the basket then the apparatus with a 
phosphate buffer solution medium of pH 6.8 at 37 ± 
0.5°C isintegration time was observed in each film. 
The film preparation was called destroyed when there 
was no more film left in the basket. Measurements 
were made of six films per formula [6]. 
The film was allowed to expand in 15 ml of 
phosphate buffer medium pH 6.8 in a petri dish. The 
film was taken from a petri dish and removed with 
filter paper then the film was weighed. Index swelling 
was calculated by the following equation [7]:  
Index swelling (%) = wt-wo × 100% 
                                     wo 
Description: 
wt: the weight at certain time t 
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wo: the weight at time 0  
Dissolution test was carried out with a paddle 
type dissolution apparatus, rotating speed 50 rpm, the 
dissolution medium of phosphate buffer pH 6.8 was 
900 ml at a temperature of 37 ± 0.5°C. A film was 
inserted into the dissolution device. Solution was 
taken as much as 2 mL at the 20
th
, 40
th
, 60
th
, 80
th
, 
100
th
, and 120
th
 seconds. Uptake the solution was 
calculated at the maximum wavelength [8].  
 
 
Results  
 
Organoleptic evaluation was one of the 
important things to be observed because ODF 
preparations directly came into contact with the oral 
cavity. The resulting ODF preparations must have a 
taste that was acceptable to many people. The use of 
HPMC polymers produced smooth, non-sticky and 
transparent film surfaces in all four formulas (Figrue 
1). 
 
Figure 1: The amlodipine besylate fast orally dissolving films 
 
Measurement of the uniformity of weight and 
thickness in the film was necessary because it was 
directly related to the amount of drug in the film. The 
ideal film thickness should be in the range of 50 to 
1000 μm [3].  
Table 2: Result of weight uniformity test and film thickness of 
amlodipine besylate fast orally dissolving films. 
Formula Weight (mg) Thickness (mm) 
F1 45.33 ± 0.516 0.057 ± 0.0009 
F2 45.50 ± 0.547 0.054 ± 0.0003 
F3 45.58 ± 0.376 0.056 ± 0.0008 
F4 45.61 ± 0.377 0.052 ± 0.0011 
Note: F1 = ODF with crospovidone 2%; F2 = ODF with crospovidone 4%; F3 = ODF with 
crospovidone 6%; F4 = ODF with crospovidone 8%. 
 
 
In Table 2, we can see that the ODF F1 had a 
weight of 45.33 ± 0.516 mm, F2 of 45.50 ± 0.547 mm, 
F3 of 45.58 ± 0.376 mm and F4 of 45.61 ± 0.377 mm. 
Based on the above results, it could be seen that 
there was little difference in the weight of the film on 
each formula, but still could be categorized quite 
uniformly. In the film thickness test results, F1 had a 
thickness of 0.057 ± 0.0009 mm, F2 of 0.054 ± 0.0003 
mm, F3 of 0.056 ± 0.0008 mm and F4 of 0.052 ± 
0.0011 mm. 
Determination of the surface pH of the film 
aimed to ensure no oral mucosal side effects because 
too acidic or alkaline pH could cause oral mucosal 
irritation. Surface pH should be neutral or near neutral 
[6]. In Table 3 it can be seen that the film preparation 
of the four formulas had a neutral pH of 6.73-6.83, so 
irritation to the oral mucosa could be avoided [9]. 
In Table 3 we can be see that the levels of 
drug obtained ranged between 97.80% and 99.46%. 
The uniformity limit of the content was 85%-115% with 
the standard deviation should be less or equal to 6% 
[10]. The content uniformity test was performed to 
ensure that all films contained a number ingredient of 
the desired drug. The uniformity of the content was 
determined by estimating the active ingredient content 
of the drug present in each film [8]. The result of 
surface pH test, and drug content in the film can be 
seen in Table 3. 
Table 3: Result of surface pH test, disintegration time, and 
drug content in the amlodipine besylate fast orally dissolving 
films 
 
Formula pH Drug levels (%) Disintegration time (sec) 
F1 6.77 ± 0.058 98.16 ± 0.178 34.66 ± 2.943 
F2 6.83 ± 0.058 99.46 ± 0.294 31.50 ± 2.880 
F3 6.80 ± 0.100 97.80 ± 0.355 39.00 ± 1.483 
F4 6.73 ± 0.058 98.28 ± 0.459 40.83 ± 1.602 
Note: F1 = ODF with crospovidone 2%; F2 = ODF with crospovidone 4%; F3 = ODF with 
crospovidone 6%; F4 = ODF with crospovidone 8%. 
 
Drug components are fully available for 
absorption digestive tract; therefore, the preparation 
must be destroyed for release the drug into body 
fluids to dissolve [11]. Disintegration time is expected 
to provide an overview of preparation time ODF is 
experiencing disintegration. In Table 3, the fastest 
disintegration time was generated by F1 compared to 
other formulas, then followed by F2, F3, and F4. 
The swelling nature of the film was usually 
due to the role of the polymer which increased the 
hydrophilicity. In many cases, inflated index rates play 
an important role in controlling drug release [3]. The 
film swelling test was carried out to see the magnitude 
of the increased film mass allowed to expand in the 
phosphor buffer solution of pH 6.8 for 20 seconds. 
The increase in mass of the film indicated an increase 
in the hydration of the film. The more water was 
absorbed, the power of swelling was better from the 
film [12]. The swelling index of the formulas can be 
seen in Table 4. 
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Table 4: The swelling index of the amlodipine besylate fast 
orally dissolving films 
Formula Time (sec) Swelling index (%) 
F1 
5 81.98 ± 1.186 
10 152.73 ± 2.357 
15 231.42 ± 4.899 
20 - 
F2 
5 96.76 ± 1.070 
10 174.93 ± 1.394 
15 242.29 ± 1.922 
20 - 
F3 
5 74.70 ± 1.159 
10 136.40 ± 1.445 
15 206.93 ± 3.382 
20 239.34 ± 1.213 
F4 
5 67.27 ± 1.538 
10 128.49 ± 0.514 
15 170.91 ± 0.214 
20 233.54 ± 4.575 
Note: F1 = ODF with crospovidone 2%; F2 = ODF with crospovidone 4%; F3 = ODF with 
crospovidone 6%; F4 = ODF with crospovidone 8%. 
 
The sequence of swelling index percentage 
was as follows F2 > F1 > F3 > F4. In F1 and F2, at the 
15
th
 second, F1 produced an swelling index of 231.42 
± 4.899% and F2 produced an swelling index of 
242.29 ± 1.922% while in the 20 seconds, F1 and F2 
were not taken into account again because at the time 
some of the films have been destroyed so that the film 
was no longer intact and the final weight of the film 
could not be weighed again. This could be attributed 
to the effect of crospovidone that helps speed up the 
film's swelling. The effects of crospovidone as 
superdisintegrant were based primarily on the ability 
to swell without forming the gel so that in the presence 
of crospovidone could accelerate the water absorption 
in the film [13]. In F3 and F4, the swelling index was 
calculated up to the 20 seconds, F3 produced a 
swelling index of 239.34 ± 1.213% and F4 produced a 
swelling index of 233.54 ± 4.575%. 
Dissolution test using paddle method and 
phosphate buffer pH 6.8 as dissolution medium. The 
parameter for stating the dissolution rate is percent 
cumulative, which is the percentage of amlodipine 
which is released from the Fast ODF dosage form at 
interval of 20, 40, 60, 80, 100 and 120 seconds with 
crospovidone concentration varied 2%, 4%, 6% and 
8%. The fastest dissolution rate was shown by F2 > 
F1 > F3 > F4. This was due to variations of the 
crospovidone concentration used in the formula. The 
results of statistical analysis showed that usage 
crospovidone with a concentration of 4% showed the 
most drug release many and in the shortest time.  
Cumulative percent yield F1 to powder exposure from 
seconds 0 to seconds 120 can be seen in Table 5. 
Crospovidone quickly wetted into the film by saliva 
resulting in an expansion of volume and hydrostatic 
pressure that occurs rapid disintegration [12]. 
Table 5: Cumulative percent average 
No. 
Time 
(sec) 
% 
cumulative 
F1 
% 
cumulative 
F2 
% cumulative 
F3 
% 
cumulative 
F4 
% cumulative 
Crospovidone 
powder 
1 20 18.09 26.28 16.47 15.93 47.61 
2 40 39.68 48.17 38.05 36.46 71.06 
3 60 65.22 71.63 63.93 62.87 98.31 
4 80 83.62 98.08 83.43 83.67 99.22 
5 100 100.03 100.62 93.72 91.68 99.87 
6 120 101.70 101.71 98.93 97.97 101.90 
Note: F1 = ODF with crospovidone 2%; F2 = ODF with crospovidone 4%; F3 = ODF with 
crospovidone 6%; F4 = ODF with crospovidone 8%. 
 
The amount of amlodipine besylate 
concentration dissolved in the medium from 0 – 120 
seconds were calculated based on the area under 
curve (AUC). Results AUC0-120 calculation can be 
seen in Table 6. AUC calculation results showed that 
the amlodipine concentration dissolved in the medium 
from 0 – 120 seconds with 2%, 4%, 6% and 8% 
variations of crossover one concentration. Drug given 
orally in solid dosage form; the bioavailability can be 
varied from zero to 100%. AUC is an important 
parameter in describing the amount of drug in the 
body. 
The results of the AUC calculation showed 
that the amlodipine concentration dissolved in the 
medium from 0 to 120 seconds was greater in the 
formula last crospovidone powder comparator for F1 
to F4, F2 using 4% crospovidone concentration had 
the largest AUC then followed by crospovidone 
concentration of 2%, then crospovidone 6% and the 
last 8%. 
Table 6: Results of AUC calculations 
Formula AUC (mcg/ml) 
Crospovidone powder 9342.46 
F1 7150.06 
F2 7912.76 
F3 6921.46 
F4 6798.53 
 
 
Discussion 
 
Crospovidone was effectively used on low 
concentration of 2-4% [8]. Unlike other 
superdisintegrants, which rely primarily swelling for 
disintegration, crospovidone uses a combination effect 
swelling and wicking so that ODF preparations can 
release drug ingredients from the dosage form quickly 
[14]. 
The conclusion of this research is amlodipine 
besylate can be formulated into fast orally dissolving 
film preparation using HPMC polymer with 
crospovidone. A variation concentration of 
crospovidone gives effect to characterization of 
amlodipine besylate fast orally dissolving films. F2 
with 4% crospovidone concentration is the best 
formula with 31.50 seconds disintegration time, 
swelling index at 15 seconds by 242.29% and percent 
cumulative drug in the 80
th
 second of 98.08%. 
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